» Articles » PMID: 23049808

LMNA Knock-down Affects Differentiation and Progression of Human Neuroblastoma Cells

Abstract

Background: Neuroblastoma (NB) is one of the most aggressive tumors that occur in childhood. Although genes, such as MYCN, have been shown to be involved in the aggressiveness of the disease, the identification of new biological markers is still desirable. The induction of differentiation is one of the strategies used in the treatment of neuroblastoma. A-type lamins are components of the nuclear lamina and are involved in differentiation. We studied the role of Lamin A/C in the differentiation and progression of neuroblastoma.

Methodology/principal Findings: Knock-down of Lamin A/C (LMNA-KD) in neuroblastoma cells blocked retinoic acid-induced differentiation, preventing neurites outgrowth and the expression of neural markers. The genome-wide gene-expression profile and the proteomic analysis of LMNA-KD cells confirmed the inhibition of differentiation and demonstrated an increase of aggressiveness-related genes and molecules resulting in augmented migration/invasion, and increasing the drug resistance of the cells. The more aggressive phenotype acquired by LMNA-KD cells was also maintained in vivo after injection into nude mice. A preliminary immunohistochemistry analysis of Lamin A/C expression in nine primary stages human NB indicated that this protein is poorly expressed in most of these cases.

Conclusions/significance: We demonstrated for the first time in neuroblastoma cells that Lamin A/C plays a central role in the differentiation, and that the loss of this protein gave rise to a more aggressive tumor phenotype.

Citing Articles

Advances in research on the relationship between the LMNA gene and human diseases (Review).

Zhao J, Zhang H, Pan C, He Q, Zheng K, Tang Y Mol Med Rep. 2024; 30(6).

PMID: 39422026 PMC: 11529173. DOI: 10.3892/mmr.2024.13358.


Biomarkers in Cancer Detection, Diagnosis, and Prognosis.

Das S, Dey M, Devireddy R, Gartia M Sensors (Basel). 2024; 24(1).

PMID: 38202898 PMC: 10780704. DOI: 10.3390/s24010037.


Knockdown of inhibits Akt/β-catenin-mediated cell invasion and migration in clear cell renal cell carcinoma cells.

Xin H, Tang Y, Jin Y, Li H, Tian Y, Yu C Cell Adh Migr. 2023; 17(1):1-14.

PMID: 37749865 PMC: 10524799. DOI: 10.1080/19336918.2023.2260644.


A biomechanical view of epigenetic tumor regulation.

Zhao B, Lv Y J Biol Phys. 2023; 49(3):283-307.

PMID: 37004697 PMC: 10397176. DOI: 10.1007/s10867-023-09633-3.


Reduced Acquired Resistance to Erlotinib in NSCLC by Reversing the Epithelial-Mesenchymal Transition via the FGFR/MAPK/c-fos Signaling Pathway.

Hu C, Zhou A, Hu X, Xiang Y, Huang M, Huang J Int J Mol Sci. 2022; 23(21).

PMID: 36362025 PMC: 9658955. DOI: 10.3390/ijms232113237.


References
1.
Wu Z, Wu L, Weng D, Xu D, Geng J, Zhao F . Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma. J Exp Clin Cancer Res. 2009; 28:8. PMC: 2632624. DOI: 10.1186/1756-9966-28-8. View

2.
Lin F, Worman H . Expression of nuclear lamins in human tissues and cancer cell lines and transcription from the promoters of the lamin A/C and B1 genes. Exp Cell Res. 1997; 236(2):378-84. DOI: 10.1006/excr.1997.3735. View

3.
Pinol-Roma S . HnRNP proteins and the nuclear export of mRNA. Semin Cell Dev Biol. 1997; 8(1):57-63. DOI: 10.1006/scdb.1996.0122. View

4.
Prokocimer M, Davidovich M, Nissim-Rafinia M, Wiesel-Motiuk N, Bar D, Barkan R . Nuclear lamins: key regulators of nuclear structure and activities. J Cell Mol Med. 2009; 13(6):1059-85. PMC: 4496104. DOI: 10.1111/j.1582-4934.2008.00676.x. View

5.
Andres V, Gonzalez J . Role of A-type lamins in signaling, transcription, and chromatin organization. J Cell Biol. 2009; 187(7):945-57. PMC: 2806284. DOI: 10.1083/jcb.200904124. View